Clinical Trial Update: Administration of Human Protein C Concentrates in Patients With Sepsis and Septic Shock. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating human protein C concentrates in patients with sepsis and septic shock has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Drugs mentioned

• Human Protein C Concentrate (protein C concentrate)

Snippet

Sponsor: University of Roma La Sapienza | Conditions: Sepsis, Septic Shock | Phase 2 | Status: COMPLETED